GA-AMCLAV FORTE 400/57 Australia - English - Department of Health (Therapeutic Goods Administration)

ga-amclav forte 400/57

actavis pty ltd - potassium clavulanate; amoxycillin trihydrate; amoxycillin (as trihydrate) -

GA-AMCLAV 125/31.25 Australia - English - Department of Health (Therapeutic Goods Administration)

ga-amclav 125/31.25

actavis pty ltd - amoxycillin trihydrate; potassium clavulanate; amoxycillin (as trihydrate) -

GA-AMCLAV 500/125 Australia - English - Department of Health (Therapeutic Goods Administration)

ga-amclav 500/125

actavis pty ltd - amoxycillin trihydrate; potassium clavulanate; amoxycillin; clavulanic acid -

GA-AMCLAV FORTE 875/125 Australia - English - Department of Health (Therapeutic Goods Administration)

ga-amclav forte 875/125

actavis pty ltd - potassium clavulanate; amoxycillin trihydrate; amoxycillin; clavulanic acid -

AMLODIPINE-GA amlodipine 10 mg (as besilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine-ga amlodipine 10 mg (as besilate) tablet blister pack

medis pharma pty ltd - amlodipine besilate, quantity: 13.868 mg (equivalent: amlodipine, qty 10 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; sodium starch glycollate type a; microcrystalline cellulose; magnesium stearate - hypertension: amlodipine-ga tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine-ga tablets are indicated for the first line treatment of chronic stable angina. amlodipine-ga may be used alone, as monotherapy or in combination with other antianginal drugs.

AMLODIPINE-GA amlodipine 5 mg (as besilate) tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

amlodipine-ga amlodipine 5 mg (as besilate) tablet blister pack

medis pharma pty ltd - amlodipine besilate, quantity: 6.934 mg (equivalent: amlodipine, qty 5 mg) - tablet, uncoated - excipient ingredients: calcium hydrogen phosphate; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a - hypertension: amlodipine-ga tablets are indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of amlodipine, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent or an angiotensin-converting enzyme inhibitor. angina: amlodipine-ga tablets are indicated for the first line treatment of chronic stable angina. amlodipine-ga may be used alone, as monotherapy or in combination with other antianginal drugs.

Gallium [Ga-67]-citraat Curium 37 MBq/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

gallium [ga-67]-citraat curium 37 mbq/ml inj. sol. i.v. vial

curium belgium s.p.r.l.-b.v.b.a. - gallium (67 ga) citrate 37 mbq/ml - solution for injection - 37 mbq/ml - gallium (ga-67) citrate 37 mbq/ml - various diagnostic radiopharmaceuticals